Membrane transporters in drug development
Open accessThe DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Abstract
Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs. This presents several key questions for drug development, including which transporters are clinically important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters. In addition, what criteria should trigger follow-up clinical studies, and which clinical studies should be conducted if needed. In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clinical studies on the currently recognized most important drug transporter interactions. The recommendations are generally intended to support clinical development and filing of a new drug application. Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clinical trial enrolment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metabolism and excretion properties of the drug molecule, and information required for drug labelling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, the human genome has been proven to have more than 400 membrane transporters, which are divided into two families: ATP binding cassette (ABC) and solute carrier (SLC) transporters [114].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Self-citationMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Cited by
Items 901–1,000 of 1,008
Uptake Transporters at the Blood–Brain Barrier and Their Role in Brain Drug Disposition
Parvez, M. M., Sadighi, A., Ahn, Y., Keller, S. F., & Enoru, J. O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102473 · Cited by 43
Chapy, H., Goracci, L., Vayer, P., Parmentier, Y., Carrupt, P., Declèves, X., Scherrmann, J., Cisternino, S., & Cruciani, G. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13258 · Cited by 42
Huo, X., Liu, Q., Wang, C., Meng, Q., Sun, H., Peng, J., Ma, X., & Liu, K. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.010 · Cited by 43
An analysis of a ‘community-driven’ reconstruction of the human metabolic network
Swainston, N., Mendes, P., & Kell, D. B. (2013) · Metabolomics · doi:10.1007/s11306-013-0564-3 · Cited by 45
Becker, M. L., Elens, L., Visser, L. E., Albert Hofman, D., Uitterlinden, A. G., van Schaik, R. H. N., & Stricker, B. H. C. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.59 · Cited by 42
Ji, C., Tschantz, W. R., Pfeifer, N. D., Ullah, M., & Sadagopan, N. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.12.005 · Cited by 43
Pavek, P., & Smutny, T. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.835819 · Cited by 42
Impact of Physiologically Based Pharmacokinetic Modeling and Simulation in Drug Development
Shardlow, C. E., Generaux, G. T., Patel, A. H., Tai, G., Tran, T. B., & Bloomer, J. C. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052803 · Cited by 42
Giacomini, M. M., Jia, H., Liang, X., Chandrasekhar, J., Twelves, J., Whitney, J. A., Lepist, E., & Ray, A. S. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.073338 · Cited by 42
Solute carrier transporters: potential targets for digestive system neoplasms
Xie, J., Zhu, X. Y., Liu, L.-M., & Meng, Z. Q. (2018) · Cancer Management and Research · doi:10.2147/cmar.s152951 · Cited by 44
Li, C. Y., Hosey, C. M., Basit, A., Unadkat, J. D., Leeder, J. S., & Prasad, B. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0359-1 · Cited by 42
Vora, B., Green, E. A. E., Khuri, N., Bällgren, F., Sirota, M., & Giacomini, K. M. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz255 · Cited by 44
Self-citationAshrafizadeh, M., Zarrabi, A., Orouei, S., Saberifar, S., Salami, S., Hushmandi, K., & Najafi, M. (2020) · Phytotherapy Research · doi:10.1002/ptr.6815 · Cited by 43
Casellas, C. P., Jansen, K., Rookmaaker, M. B., Clevers, H. C., Verhaar, M. C., & Masereeuw, R. (2021) · Physiological Reviews · doi:10.1152/physrev.00009.2021 · Cited by 45
Transporter assays as useful in vitro tools in drug discovery and development
Volpe, D. A. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1101064 · Cited by 42
Current understanding of hepatic and intestinal OATP-mediated drug–drug interactions
Koenen, A., Kroemer, H. K., Grube, M., & zu Schwabedissen, H. E. M. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.58 · Cited by 44
Three dimensional human small intestine models for ADME-Tox studies
Yu, J., Carrier, R. L., March, J. C., & Griffith, L. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.05.003 · Cited by 47
Oral Pharmacokinetics of Hydroxycinnamic Acids: An Updated Review
Veras, K. S., Fachel, F. N. S., de Araújo, B. V., Teixeira, H. F., & Koester, L. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122663 · Cited by 47
In Silico and In Vitro Analyses to Repurpose Quercetin as a Human Pancreatic α-Amylase Inhibitor
Raut, B. K., Upadhyaya, S. R., Bashyal, J., & Parajuli, N. (2023) · ACS Omega · doi:10.1021/acsomega.3c05082 · Cited by 44
Ronaldson, P. T., & Davis, T. P. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2306138 · Cited by 45
Standardization and quality assessment for human intestinal organoids
Lee, H., Yang, S., Lee, K. J., Kim, S.-N., Jeong, J., Kim, K. Y., Jung, C., Jeon, S., Kwon, D., Lee, S., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1383893 · Cited by 44
Drug interactions with statins
Čaušević-Ramoševac, A., & Semiz, S. (2013) · Acta Pharmaceutica · doi:10.2478/acph-2013-0022 · Cited by 49
Kirchheiner, J., & Brockmöller, J. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.274 · Cited by 50
Oxazaphosphorine bioactivation and detoxification: the role of xenobiotic receptors
Wang, D., & Wang, H. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.02.004 · Cited by 41
Lundquist, P., Lööf, J., Sohlenius-Sternbeck, A.-K., Floby, E., Johansson, J., Bylund, J., Hoogstraate, J. A., Afzelius, L., & Andersson, T. B. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054676 · Cited by 46
Reduced ABCB1 Expression and Activity in the Presence of Acrylic Copolymers
Mohammadzadeh, R., Baradaran, B., Valizadeh, H., Yousefi, B., & Zakeri‐Milani, P. (2014) · Europe PMC (PubMed Central) · doi:10.5681/apb.2014.032 · Cited by 42
Quantitative Structure-Pharmacokinetic Relationships for the Prediction of Renal Clearance in Humans
Dave, R. A., & Morris, M. E. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059857 · Cited by 41
Interaction of Digitalis-Like Compounds with Liver Uptake Transporters NTCP, OATP1B1, and OATP1B3
Gozalpour, E., Greupink, R., Wortelboer, H. M., Bilos, A., Schreurs, M., Rüssel, F. G. M., & Koenderink, J. B. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400699p · Cited by 43
Highly Parallel Transport Recordings on a Membrane-on-Nanopore Chip at Single Molecule Resolution
Urban, M., Kleefen, A., Mukherjee, N., Seelheim, P., Windschiegl, B., der Brüggen, M. V., Koçer, A., & Tampé, R. (2014) · Nano Letters · doi:10.1021/nl5002873 · Cited by 41
A new paradigm for navigating compound property related drug attrition
Barton, P., & Riley, R. J. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.09.010 · Cited by 48
Zhang, A., Jia, Y., Xu, Q., Wang, C., Liu, Q., Meng, Q., Peng, J., Sun, H., Sun, P., Huo, X., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.06.019 · Cited by 41
Bagal, S. K., Andrews, M. D., Bechle, B. M., Bian, J., Bilsland, J., Blakemore, D. C., Braganza, J., Bungay, P. J., Corbett, M. S., Cronin, C. N., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00633 · Cited by 43
Minhas, G. S., & Newstead, S. L. (2020) · Biochemical Society Transactions · doi:10.1042/bst20180302 · Cited by 41
Immunogenic Cell Death: A Step Ahead of Autophagy in Cancer Therapy
Gupta, G., Borglum, K., & Chen, H. (2021) · Journal of Cancer Immunology · doi:10.33696/cancerimmunol.3.041 · Cited by 61
Temesszentandrási‐Ambrus, C., Bakos, É., Sarkadi, B., Özvegy‐Laczka, C., & Telbisz, Á. (2021) · Scientific Reports · doi:10.1038/s41598-021-97160-3 · Cited by 43
Zhao, J., Zhao, Q. S., Lu, J., Ye, D., Mu, S., Yang, X., Zhang, W., & Ma, B. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s323685 · Cited by 42
Joy, M. S., Frye, R. F., Nolin, T. D., Roberts, B. V., La, M. K., Wang, J., Brouwer, K. L. R., Dooley, M. A., & Falk, R. J. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1347 · Cited by 41
Self-citationProtective Mechanisms of Hypothermia in Liver Surgery and Transplantation
Olthof, P. B., Reiniers, M. J., Dirkes, M. C., van Gulik, T. M., Heger, M., & van Golen, R. F. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00158 · Cited by 43
ATP Binding Cassette Transporters and Cancer: Revisiting Their Controversial Role
Sharma, P., Singh, N., & Sharma, S. (2021) · Pharmacogenomics · doi:10.2217/pgs-2021-0116 · Cited by 41
Lima, Á., Bernardes, M., Azevedo, R., Medeiros, R., & Seabra, V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160613760 · Cited by 40
Intracellular concentrations determine the cytotoxicity of adefovir, cidofovir and tenofovir
Zhang, X., Wang, R., Piotrowski, M. A., Zhang, H., & Leach, K. L. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.10.019 · Cited by 36
Hume, W. E., Shingaki, T., Takashima, T., Hashizume, Y., Okauchi, T., Katayama, Y., Hayashinaka, E., Wada, Y., Kusuhara, H., Sugiyama, Y., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.10.041 · Cited by 40
Self-citationFenyvesi, F., Kiss, T., Fenyvesi, É., Szente, L., Veszelka, S., Deli, M. A., Váradi, J., Fehér, P. S., Ujhelyi, Z., Tósaki, Á., et al. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22666 · Cited by 40
Furuta, S., Smart, C., Hackett, A., Benning, R. K., & Warrington, S. (2012) · Xenobiotica · doi:10.3109/00498254.2012.731618 · Cited by 41
OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture
Ulvestad, M., Björquist, P., Molden, E., Åsberg, A., & Andersson, T. B. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.076 · Cited by 40
Rapid detection of ABC transporter interaction: Potential utility in pharmacology
Robey, R. W., Lin, B., Qiu, J., Chan, L. L., & Bates, S. E. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.11.003 · Cited by 40
Jiménez‐Nácher, I., Alvarez, E., Morelló, J., Rodríguez‐Nóvoa, S., de Andrés, S., & Soriano, V. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.558839 · Cited by 40
Macitentan Does Not Interfere with Hepatic Bile Salt Transport
Treiber, A., Äänismaa, P., de Kanter, R., Delahaye, S., Treher, M., Hess, P., & Sidharta, P. N. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214106 · Cited by 43
Impact of the Pharmaceutical Sciences on Health Care: A Reflection over the Past 50 Years
Rowland, M., Noe, C. R., Smith, D. A., Tucker, G. T., Crommelin, D. J. A., Peck, C. C., Rocci, M. L., Besançon, L., & Shah, V. P. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23295 · Cited by 49
Mendell, J., Noveck, R. J., & Shi, M. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31826265b6 · Cited by 42
CRISPR-Cas9: A New Addition to the Drug Metabolism and Disposition Tool Box
Karlgren, M., Simoff, I., Keiser, M., Oswald, S., & Artursson, P. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.082842 · Cited by 42
Zhu, Z., Chung, Y., Sergeeva, O., Kepe, V., Berk, M. P., Li, J., Ko, H., Li, Z., Petro, M., DiFilippo, F. P., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004846 · Cited by 42
Structural biology and structure–function relationships of membrane proteins
Reis, R. I., & Moraes, I. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180269 · Cited by 41
Heo, C. U., & Choi, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030393 · Cited by 43
Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity
Pan, G. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_6 · Cited by 40
Chen, C., Ai, Q., & Wei, Y. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113388 · Cited by 41
Mazur, C. S., Marchitti, S. A., & Zastre, J. A. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.09.020 · Cited by 40
Pharmacogenetics of Drug Transporters in the Enterohepatic Circulation
Stieger, B., & Meier, P. J. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.53 · Cited by 41
Predicting when Biliary Excretion of Parent Drug is a Major Route of Elimination in Humans
Hosey, C. M., Broccatelli, F., & Benet, L. Z. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9636-1 · Cited by 42
Self-citationCaetano-Pinto, P., Jansen, J., Assaraf, Y. G., & Masereeuw, R. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.01.002 · Cited by 42
Fong, S. Y. K., Li, C., Ho, Y. C., Li, R., Wang, Q., Wong, Y. C., Xue, H., & Zuo, Z. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00029 · Cited by 40
Xu, P., Zhou, H., Li, Y., Yuan, Z., Liu, C., Liu, L., & Xie, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01115 · Cited by 41
Aldosterone: Renal Action and Physiological Effects
Johnston, J. G., Welch, A., Cain, B. D., Sayeski, P. P., Gumz, M. L., & Wingo, C. S. (2023) · Comprehensive physiology · doi:10.1002/cphy.c190043 · Cited by 49
Calcein assay: a high-throughput method to assess P-gp inhibition
Glavinas, H., von Richter, O., Vojnits, K., Méhn, D., Wilhelm, I., Nagy, T., Jánossy, J., Krizbai, I. A., Couraud, P., & Krajcsi, P. (2011) · Xenobiotica · doi:10.3109/00498254.2011.587033 · Cited by 39
Elsby, R., Smith, V., Fox, L. G., Stresser, D. M., Butters, C., Sharma, P. K., & Surry, D. D. (2011) · Xenobiotica · doi:10.3109/00498254.2011.578761 · Cited by 39
Non-invasive imaging in experimental medicine for drug development
Matthews, P. M., Rabiner, I., & Gunn, R. N. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.009 · Cited by 44
Long-Lasting Inhibitory Effects of Saquinavir and Ritonavir on OATP1B1-Mediated Uptake
Shitara, Y., Takeuchi, K., & Horie, T. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23477 · Cited by 39
Newstead, S. L. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391353 · Cited by 39
Badolo, L., Jensen, B., Säll, C., Norinder, U., Kallunki, P., & Montanari, D. (2014) · Xenobiotica · doi:10.3109/00498254.2014.955831 · Cited by 39
Gallegos, T. F., Martovetsky, G., Kouznetsova, V. L., Bush, K. T., & Nigám, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040796 · Cited by 40
Macha, S., Koenen, R., Sennewald, R., Schöne, K., Hummel, N., Riedmaier, S., Woerle, H. J., Salsali, A., & Broedl, U. C. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.01.003 · Cited by 40
Emtricitabine is a substrate of MATE1 but not of OCT1, OCT2, P-gp, BCRP or MRP2 transporters
Reznicek, J., Čečková, M., Červený, L., Müller, F., & Štaud, F. (2016) · Xenobiotica · doi:10.3109/00498254.2016.1158886 · Cited by 39
Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid Tumors
Fruci, D., Cho, W. C. S., Romania, P., Nobili, V., Locatelli, F., & Alisi, A. (2016) · Current Drug Metabolism · doi:10.2174/1567205010666131212110948 · Cited by 39
Lukacova, V., Goelzer, P., Reddy, M. B., Greig, G., Reigner, B. G., & Parrott, N. J. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9956-4 · Cited by 39
Kosa, R. E., Lazzaro, S., Bi, Y., Tierney, B., Gates, D., Modi, S., Costales, C., Rodrigues, A. D., Tremaine, L. M., & Varma, M. V. S. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081794 · Cited by 41
Welink, J., Xu, Y., Yang, E., Wilson, A., Henderson, N., Luo, L., Fraser, S., Kavita, U., Musuku, A., James, C. A., et al. (2018) · Bioanalysis · doi:10.4155/bio-2018-0268 · Cited by 39
O’Hagan, S., & Kell, D. B. (2017) · ADMET & DMPK · doi:10.5599/admet.5.2.376 · Cited by 40
Conner, K. P., Devanaboyina, S. C., Thomas, V. A., & Rock, D. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107574 · Cited by 41
Pharmacokinetics and Toxicokinetics Roles of Membrane Transporters at Kidney Level
Veiga-Matos, J., Remião, F., & Motales, A. (2020) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30865 · Cited by 43
A Method to Measure Hydrolytic Activity of Adenosinetriphosphatases (ATPases)
Bartolommei, G., Moncelli, M. R., & Tadini‐Buoninsegni, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058615 · Cited by 45
Chiou, W. J. H., de Morais, S. M., Kikuchi, R., Voorman, R. L., Li, X., & Bow, D. A. J. (2013) · Xenobiotica · doi:10.3109/00498254.2013.820006 · Cited by 39
Characterization of SLCO5A1/OATP5A1, a Solute Carrier Transport Protein with Non-Classical Function
Sebastian, K., Detro‐Dassen, S., Rinis, N., Fahrenkamp, D., Müller‐Newen, G., Merk, H. F., Schmalzing, G., Zwadlo‐Klarwasser, G., & Baron, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083257 · Cited by 39
Zamek‐Gliszczynski, M. J., Day, J. S., Hillgren, K. M., & Phillips, D. L. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040162 · Cited by 39
Self-citationLee, J.-H., Noh, C., Yim, C.-S., Jeong, Y., Ahn, S. H., Lee, W., Kim, D., & Chung, S. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24378 · Cited by 39
Jia, W., Du, F., Liu, X., Jiang, R., Xu, F., Yang, J., Li, L., Wang, F., Olaleye, O. E., Dong, J., et al. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.062000 · Cited by 39
Alam, K., Pahwa, S., Wang, X., Zhang, P., Ding, K., Abuznait, A. H., Li, L., & Yue, W. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00763 · Cited by 39
Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug–Drug Interactions in Vivo
Durmuş, S., Lozano‐Mena, G., van Esch, A., Wagenaar, E., van Tellingen, O., & Schinkel, A. H. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00453 · Cited by 39
Wu, J., Zhu, Y., Li, F., Zhang, G., Shi, J., Ou, R., Tong, Y., Liu, Y., Liu, L., Lu, L., et al. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.07.021 · Cited by 42
Clinically Relevant Multidrug Transporters Are Regulated by microRNAs along the Human Intestine
Bruckmueller, H., Martin, P. D., Kaehler, M., Haenisch, S., Ostrowski, M., Droździk, M., Siegmund, W., Cascorbi, I., & Oswald, S. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00076 · Cited by 41
Efflux transport of estrogen glucuronides by human MRP2, MRP3, MRP4 and BCRP
Järvinen, E., Deng, F. Y., Kidron, H., & Finel, M. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.11.007 · Cited by 40
Wassenaar, J. W., Boss, G. R., & Christman, K. L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.033 · Cited by 39
Alves, L. D. F., Moore, J. B., & Kell, D. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169082 · Cited by 43
Computational frameworks transform antagonism to synergy in optimizing combination therapies
Chen, J., Lin, A., Jiang, A., Qi, C., Liu, Z., Cheng, Q., Yuan, S., & Luo, P. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01435-2 · Cited by 46
Khin, N. A., Yang, P., Hung, H., Maung-U, K., Chen, Y.-F., Meeker-O’Connell, A., Okwesili, P., Yasuda, S. U., Ball, L. K., Sm, H., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.70 · Cited by 38
Zhang, X., Dong, D., Wang, H., Ma, Z., Wang, Y., & Wu, B. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5008019 · Cited by 38
Attolitre-sized lipid bilayer chamber array for rapid detection of single transporters
Soga, N., Watanabe, R., & Noji, H. (2015) · Scientific Reports · doi:10.1038/srep11025 · Cited by 39
Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction
Mao, Q., Lai, Y., & Wang, J. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081356 · Cited by 38
Xu, L., Liu, J., Xi, J., Li, Q., Chang, B., Duan, X., Wang, G., Wang, S., Wang, Z., & Wang, L. (2018) · Small · doi:10.1002/smll.201800785 · Cited by 38
A Comprehensive Overview of the Clinical Pharmacokinetics of Clobazam
Tolbert, D. S., & Larsen, F. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1313 · Cited by 43
Metadata
- Authors
- The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., Hoffmaster, K. A., Ishikawa, T., Keppler, D., Kim, R. B., Lee, C. A., Niemi, M., Polli, J. W., Sugiyama, Y., Swaan, P. W., Ware, J. A., Wright, S. H., Wah Yee, S., Zamek-Gliszczynski, M. J., & Zhang, L.
- Affiliations
- University of California, San Francisco (US)
- United States Food and Drug Administration (US)
- Boehringer Ingelheim (United States) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Abbott (United States) (US)
- Eli Lilly (United States) (US)
- Novartis (United States) (US)
- RIKEN (JP)
- German Cancer Research Center (DE)
- Western University (CA)
- GlaxoSmithKline (United Kingdom) (GB)
- Genentech (US)
- University of Maryland, Baltimore (US)
- University of Arizona (US)
- ORCID
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-03
- Volume
- 9
- Issue
- 3
- Pages
- 215-236
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3326076
- OpenAlex
- W2079197876
- Cited by
- 3,340
- References
- 225
- Citations by year
- 2026: 105 · 2025: 118 · 2024: 153 · 2023: 175 · 2022: 180 · 2021: 237 · 2020: 187 · 2019: 219 · 2018: 234 · 2017: 216 · 2016: 242 · 2015: 233 · 2014: 248 · 2013: 316 · 2012: 254
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- National Institutes of Health (GM61390)
- U.S. Food and Drug Administration
- National Institute of General Medical Sciences (GM61390, R01GM041935, U19GM061390, U01GM061390)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080801, R01DK061425)
- National Institute of Environmental Health Sciences (P30ES006694)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- membrane transporters, drug transporters, drug-drug interactions, pharmacokinetics, drug absorption, drug disposition, drug development, drug safety and efficacy, drug labeling
- MeSH terms
- Animals, Computer Simulation, Decision Trees, Drug Interactions, Drug Evaluation, Preclinical, Humans, Drug Approval, Mice, Knockout, Membrane Transport Proteins, Mice, Prescription Drugs, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.